Plasma membrane domain organization regulates EGFR signaling in tumor cells

Journal of Cell Biology

Volumn 179, Issue 2, 2007, Pages 341-356

  Lajoie, Patrick ^a   Partridge, Emily A ^b   Guay, Ginette ^c   Goetz, Jacky G ^a,c   Pawling, Judy ^b   Lagana, Annick ^d   Bharat, Joshi ^a   Dennis, James W ^b,e,f   Nabi, Ivan R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CAVEOLIN 1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORESCEIN ISOTHIOCYANATE; GALECTIN; GLYCAN; LACTOSE; SMALL INTERFERING RNA; SUCROSE; YELLOW FLUORESCENT PROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CELL GROWTH; CELL MEMBRANE; CONTROLLED STUDY; CYTOSKELETON; ELECTRON MICROSCOPY; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; MOUSE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR CELL; VIRUS INFECTION; WESTERN BLOTTING;

ACTINS; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CAVEOLIN 1; CELL MEMBRANE; CYTOSKELETON; DIFFUSION; EMBRYONIC STEM CELLS; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GALECTINS; MICE; MODELS, BIOLOGICAL; NEOPLASMS; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; THIAZOLIDINES;

EID: 35549010724     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200611106     Document Type: Article

References (71)

1. Ahmad, N., H.J. Gabius, S. Andre, H. Kaltner, S. Sabesan, R. Roy, B. Liu, F. Macaluso, and C.F. Brewer. 2004. Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J. Biol. Chem. 279:10841-10847.
2. Bauer, P.M., J. Yu, Y. Chen, R. Hickey, P.N. Bernatchez, R. Looft-Wilson, Y. Huang, F. Giordano, R.V. Stan, and W.C. Sessa. 2005. Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proc. Natl. Acad. Sci. USA.. 102:204-209.
3. Breuza, L., S. Corby, J.P. Arsanto, M.H. Delgrossi, P. Scheiffele, and A. Le Bivic. 2002. The scaffolding domain of caveolin 2 is responsible for its Golgi localization in Caco-2 cells. J. Cell Sci. 115:4457-4467.
4. Brewer, C.F., M.C. Miceli, and L.G. Baum. 2002. Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr. Opin. Struct. Biol. 12:616-623.
5. Capozza, F., T.M. Williams, W. Schubert, S. McClain, B. Bouzahzah, F. Sotgia, and M.P. Lisanti. 2003. Absence of Caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. Am. J. Pathol. 162:2029-2039.
6. Chen, Y., W.R. Thelin, B. Yang, S.L. Milgram, and K. Jacobson. 2006. Transient anchorage of cross-linked glycosyl-phosphatidylinositol-anchored proteins depends on cholesterol, Src family kinases, caveolin, and phosphoinositides. J. Cell Biol. 175:169-178.
7. Cheung, P., and J.W. Dennis. 2007. Mgat5 and Pten interact to regulate cell growth and polarity. Glycobiology. 17:767-773.
8. Couet, J., M. Sargiacomo, and M.P. Lisanti. 1997. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272:30429-30438.
9. Demetriou, M., M. Granovsky, S. Quaggin, and J.W. Dennis. 2001. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature. 409:733-739.
10. Dennis, J.W., J. Pawling, P. Cheung, E. Partridge, and M. Demetriou. 2002. UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,6 N- acetylglucosaminyltransferase V (Mgat5) deficient mice. Biochim. Biophys. Acta. 1573:414-422.
11. Di Guglielmo, G.M., C. Le Roy, A.F. Goodfellow, and J.L. Wrana. 2003. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat. Cell Biol. 5:410-421.
12. Dietrich, C., B. Yang, T. Fujiwara, A. Kusumi, and K. Jacobson. 2002. Relationship of lipid rafts to transient confinement zones detected by single particle tracking. Biophys. J. 82:274-284.
13. Edidin, M., S.C. Kuo, and M.P. Sheetz. 1991. Lateral movements of membrane glycoproteins restricted by dynamic cytoplasmic barriers. Science. 254:1379-1382.
14. Ewers, H., A.E. Smith, I.F. Sbalzarini, H. Lilie, P. Koumoutsakos, and A. Helenius. 2005. Single-particle tracking of murine polyoma virus-like particles on live cells and artificial membranes. Proc. Natl. Acad. Sci. USA.. 102:15110-15115.
15. Fra, A.M., E. Williamson, K. Simons, and R.G. Parton. 1995. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc. Natl. Acad. Sci. USA.. 92:8655-8659.
16. Frick, M., K. Schmidt, and B.J. Nichols. 2007. Modulation of lateral diffusion in the plasma membrane by protein density. Curr. Biol. 17:462-467.
17. Fujiwara, T., K. Ritchie, H. Murakoshi, K. Jacobson, and A. Kusumi. 2002. Phospholipids undergo hop diffusion in compartmentalized cell membrane. J. Cell Biol. 157:1071-1082.
18. Gaidarov, I., F. Santini, R.A. Warren, and J.H. Keen. 1999. Spatial control of coated-pit dynamics in living cells. Nat. Cell Biol. 1:1-7.
19. Granovsky, M., J. Fata, J. Pawling, W.J. Muller, R. Khokha, and J.W. Dennis. 2000. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat. Med. 6:306-312.
20. Hancock, J.F. 2006. Lipid rafts: contentious only from simplistic standpoints. Nat. Rev. Mol. Cell Biol. 7:456-462.
21. Hayashi, K., S. Matsuda, K. Machida, T. Yamamoto, Y. Fukuda, Y. Nimura, T. Hayakawa, and M. Hamaguchi. 2001. Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res. 61:2361-2364.
22. Heuser, J.E., and M.W. Kirschner. 1980. Filament organization revealed in platinum replicas of freeze-dried cytoskeletons. J. Cell Biol. 86:212-234.
23. Hirabayashi, J., T. Hashidate, Y. Arata, N. Nishi, T. Nakamura, M. Hirashima, T. Urashima, T. Oka, M. Futai, W.E. Muller, et al. 2002. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim. Biophys. Acta. 1572:232-254.
24. Jacobson, K., E.D. Sheets, and R. Simson. 1995. Revisiting the fluid mosaic model of membranes. Science. 268:1441-1442.
25. Kusumi, A., I. Koyama-Honda, and K. Suzuki. 2004. Molecular dynamics and interactions for creation of stimulation-induced stabilized rafts from small unstable steady-state rafts. Traffic. 5:213-230.
26. Kusumi, A., H. Ike, C. Nakada, K. Murase, and T. Fujiwara. 2005a. Single-molecule tracking of membrane molecules: plasma membrane compartmentalization and dynamic assembly of raft-philic signaling molecules. Semin. Immunol. 17:3-21.
27. Kusumi, A., C. Nakada, K. Ritchie, K. Murase, K. Suzuki, H. Murakoshi, R.S. Kasai, J. Kondo, and T. Fujiwara. 2005b. Paradigm shift of the plasma membrane concept from the two-dimensional continuum fluid to the partitioned fluid: high-speed single-molecule tracking of membrane molecules. Annu. Rev. Biophys. Biomol. Struct. 34:351-378.
28. Lagana, A., J.G. Goetz, P. Cheung, A. Raz, J.W. Dennis, and I.R. Nabi. 2006. Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells. Mol. Cell. Biol. 26:3181-3193.
29. Lau, K.S., E.A. Partridge, A. Grigorian, C.I. Silvescu, V.N. Reinhold, M. Demetriou, and J.W. Dennis. 2007. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell. 129:123-134.
30. Le, P.U., G. Guay, Y. Altschuler, and I.R. Nabi. 2002. Caveolin-1 is a negative regulator of caveolae-mediated endocytosis to the endoplasmic reticulum. J. Biol. Chem. 277:3371-3379.
31. Lee, H., D.S. Park, B. Razani, R.G. Russell, R.G. Pestell, and M.P. Lisanti. 2002. Caveolin-1 mutations (P132L and Null) and the pathogenesis of breast cancer: caveolin-1 (p132l) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia. Am. J. Pathol. 161:1357-1369.
32. Li, S., R. Seitz, and M.P. Lisanti. 1996. Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J. Biol. Chem. 271:3863-3868.
33. Livneh, E., M. Benveniste, R. Prywes, S. Felder, Z. Kam, and J. Schlessinger. 1986. Large deletions in the cytoplasmic kinase domain of the epidermal growth factor receptor do not affect its laternal mobility. J. Cell Biol. 103:327-331.
34. Matveev, S.V., and E.J. Smart. 2002. Heterologous desensitization of EGF receptors and PDGF receptors by sequestration in caveolae. Am. J. Physiol. Cell Physiol. 282:C935-C946.
35. Mayor, S., and M. Rao. 2004. Rafts: scale-dependent, active lipid organization at the cell surface. Traffic. 5:231-240.
36. Mineo, C., G.N. Gill, and R.G. Anderson. 1999. Regulated migration of epidermal growth factor receptor from caveolae. J. Biol. Chem. 274:30636-30643.
37. Monier, S., R.G. Parton, F. Vogel, J. Behlke, A. Henske, and T.V. Kurzchalia. 1995. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol. Biol. Cell. 6:911-927.
38. Monier, S., D.J. Dietzen, W.R. Hastings, D.M. Lublin, and T.V. Kurzchalia. 1996. Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol. FEBS Lett. 388:143-149.
39. Morone, N., T. Fujiwara, K. Murase, R.S. Kasai, H. Ike, S. Yuasa, J. Usukura, and A. Kusumi. 2006. Three-dimensional reconstruction of the membrane skeleton at the plasma membrane interface by electron tomography. J. Cell Biol. 174:851-862.
40. Murakoshi, H., R. Iino, T. Kobayashi, T. Fujiwara, C. Ohshima, A. Yoshimura, and A. Kusumi. 2004. Single-molecule imaging analysis of Ras activation in living cells. Proc. Natl. Acad. Sci. USA.. 101:7317-7322.
41. Nichols, B.J., A.K. Kenworthy, R.S. Polishchuk, R. Lodge, T.H. Roberts, K. Hirschberg, R.D. Phair, and J. Lippincott-Schwartz. 2001. Rapid cycling of lipid raft markers between the cell surface and Golgi complex. J. Cell Biol. 153:529-541.
42. Nieminen, J., A. Kuno, J. Hirabayashi, and S. Sato. 2007. Visualization of galectin-3 oligomerization on the surface of neutrophils and endothelial cells using fluorescence resonance energy transfer. J. Biol. Chem. 282:1374-1383.
43. Nystrom, F.H., H. Chen, L.N. Cong, Y. Li, and M.J. Quon. 1999. Caveolin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected Cos-7 cells and rat adipose cells. Mol. Endocrinol. 13:2013-2024.
44. Okamoto, T., A. Schlegel, P.E. Scherer, and M.P. Lisanti. 1998. Caveolins, a family of scaffolding proteins for organizing preassembled signaling complexes at the plasma membrane. J. Biol. Chem. 273:5419-5422.
45. Parton, R.G., and K. Simons. 2007. The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 8:185-194.
46. Parton, R.G., M. Hanzal-Bayer, and J.F. Hancock. 2006. Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J. Cell Sci. 119:787-796.
47. Partridge, E.A., C. Le Roy, G.M. Di Guglielmo, J. Pawling, P. Cheung, M. Granovsky, I.R. Nabi, J.L. Wrana, and J.W. Dennis. 2004. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science. 306:120-124.
48. Pelkmans, L., T. Burli, M. Zerial, and A. Helenius. 2004. Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell. 118:767-780.
49. Plowman, S.J., C. Muncke, R.G. Parton, and J.F. Hancock. 2005. H-ras, K-ras, and inner plasma membrane raft proteins operate in nanoclusters with differential dependence on the actin cytoskeleton. Proc. Natl. Acad. Sci. USA. 102:15500-15505.
50. Pralle, A., P. Keller, E.-L. Florin, K. Simons, and J.K.H. Horber. 2000. Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J. Cell Biol. 148:997-1008.
51. Puri, C., D. Tosoni, R. Comai, A. Rabellino, D. Segat, F. Caneva, P. Luzzi, P.P. Di Fiore, and C. Tacchetti. 2005. Relationships between EGFR signaling-competent and endocytosis-competent membrane microdomains. Mol. Biol. Cell. 16:2704-2718.
52. Razani, B., Y. Altschuler, L. Zhu, R.G. Pestell, K.E. Mostov, and M.P. Lisanti. 2000. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation. Biochemistry. 39:13916-13924.
53. Razani, B., X.L. Zhang, M. Bitzer, G. von Gersdorff, E.P. Bottinger, and M.P. Lisanti. 2001. Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. J. Biol. Chem. 276:6727-6738.
54. Reits, E.A., and J.J. Neefjes. 2001. From fixed to FRAP: measuring protein mobility and activity in living cells. Nat. Cell Biol. 3:E145-E147.
55. Ren, X., A.G. Ostermeyer, L.T. Ramcharan, Y. Zeng, D.M. Lublin, and D.A. Brown. 2004. Conformational defects slow Golgi exit, block oligomerization, and reduce raft affinity of caveolin-1 mutant proteins. Mol. Biol. Cell. 15:4556-4567.
56. Rothberg, K.G., J.E. Heuser, W.C. Donzell, Y.-S. Ying, J.R. Glenney, and R.G.W. Anderson. 1992. Caveolin, a protein component of caveolae membrane coats. Cell. 68:673-682.
57. Sargiacomo, M., P.E. Scherer, Z. Tang, E. Kubler, K.S. Song, M.C. Sanders, and M.P. Lisanti. 1995. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc. Natl. Acad. Sci. USA. 92:9407-9411.
58. Savage, K., M.B.K. Lambros, D. Robertson, R.L. Jones, C. Jones, A. Mackay, M. James, J.L. Hornick, E.M. Pereira, F. Milanezi, et al. 2007. Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Clin. Cancer Res. 13:90-101.
59. Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1:31-39.
60. Smart, E.J., G.A. Graf, M.A. McNiven, W.C. Sessa, J.A. Engelman, P.E. Scherer, T. Okamoto, and M.P. Lisanti. 1999. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 19:7289-7304.
61. Smith, S.M.L., Y. Lei, J. Liu, M.E. Cahill, G.M. Hagen, B.G. Barisas, and D.A. Roess. 2006. Luteinizing hormone receptors translocate to plasma membrane microdomains after binding of human chorionic gonadotropin. Endocrinology. 147:1789-1795.
62. Suzuki, K.G., T.K. Fujiwara, M. Edidin, and A. Kusumi. 2007a. Dynamic recruitment of phospholipase C gamma at transiently immobilized GPI-anchored receptor clusters induces IP3-Ca2+ signaling: single-molecule tracking study 2. J. Cell Biol. 177:731-742.
63. Suzuki, K.G., T.K. Fujiwara, F. Sanematsu, R. Iino, M. Edidin, and A. Kusumi. 2007b. GPI-anchored receptor clusters transiently recruit Lyn and G alpha for temporary cluster immobilization and Lyn activation: single-molecule tracking study 1. J. Cell Biol. 177:717-730.
64. Suzuoki, M., M. Miyamoto, K. Kato, K. Hiraoka, T. Oshikiri, Y. Nakakubo, A. Fukunaga, T. Shichinohe, T. Shinohara, T. Itoh, et al. 2002. Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. Br. J. Cancer. 87:1140-1144.
65. Thomsen, P., K. Roepstorff, M. Stahlhut, and B. van Deurs. 2002. Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking. Mol. Biol. Cell. 13:238-250.
66. van Deurs, B., K. Roepstorff, A.M. Hommelgaard, and K. Sandvig. 2003. Caveolae: anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol. 13:92-100.
67. Verkade, P., T. Harder, F. Lafont, and K. Simons. 2000. Induction of caveolae in the apical plasma membrane of Madin-Darby canine kidney cells. J. Cell Biol. 148:727-739.
68. Williams, T.M., and M.P. Lisanti. 2005. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am. J. Physiol. Cell Physiol. 288:C494-C506.
69. Williams, T.M., M.W.-C. Cheung, D.S. Park, B. Razani, A.W. Cohen, W.J. Muller, D. Di Vizio, N.G. Chopra, R.G. Pestell, and M.P. Lisanti. 2003. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice. Mol. Biol. Cell. 14:1027-1042.
70. Yang, G., L.D. Truong, T.M. Wheeler, and T.C. Thompson. 1999. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res. 59:5719-5723.
71. Zhang, W., B. Razani, Y. Altschuler, B. Bouzahzah, K.E. Mostov, R.G. Pestell, and M.P. Lisanti. 2000. Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1. J. Biol. Chem. 275:20717-20725.